Department of Otolaryngology - Head & Neck Surgery, University of Toronto, Toronto, ON, Canada.
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Qual Life Res. 2021 Jan;30(1):293-301. doi: 10.1007/s11136-020-02609-z. Epub 2020 Aug 26.
The skull base inventory (SBI) was developed to better assess health-related quality of life (HR-QOL) in patients with anterior and central skull base neoplasms treated by endoscopic and open approaches. The primary objective of this study was to prospectively assess the psychometric properties of the SBI.
This study is part of a multi-center study of patients undergoing endoscopic and open procedures completed between 2012 and 2018. Participants were eligible if they were over 18 years of age; had benign or malignant anterior, antero-lateral, or central skull base tumors; and required either an open or endoscopic skull base surgical approach. In order to assess the psychometric properties of the SBI, patients completed the instrument at six time points (preoperative, 2 weeks, 3 months, 6 months, 12 months postoperative). Patients also completed the Anterior Skull Base (ASB) questionnaire and the Sinonasal Outcome Test (SNOT-22) to allow comparison to the SBI.
One hundred and eighty-seven patients were included across five centers, with 121 having an endoscopic procedure. Internal consistency (Cronbach's alpha = 0.95) and test-retest at 12 months and 12 months plus 2 weeks (intraclass correlation > 0.90) were excellent. Concurrent validity was demonstrated by very strong correlation between total SBI scores and ASB scores (r = 0.810 to 0.869, p < 0.001) and moderate correlation between nasal domain SBI scores and SNOT-22 scores (r = - 0.616 to - 0.738, p < 0.001). Convergent validity was demonstrated by moderate correlation between change in SBI scores and global QOL change (r = 0.4942, p < 0.001). The minimally important clinical difference (global HR-QOL change of "a little better" or "a little worse") was 6.0.
The SBI questionnaire is reliable and valid for patients treated by both endoscopic and open approaches and can be used for assessment of HR-QOL in these settings.
头骨基底清单(SBI)的开发是为了更好地评估接受内镜和开放方法治疗的前颅底和中央颅底肿瘤患者的健康相关生活质量(HR-QOL)。本研究的主要目的是前瞻性评估 SBI 的心理测量特性。
这项研究是 2012 年至 2018 年间进行的内镜和开放手术多中心研究的一部分。如果患者年龄超过 18 岁;患有良性或恶性前颅底、前外侧或中央颅底肿瘤;需要开放或内镜颅底手术方法,则有资格参加。为了评估 SBI 的心理测量特性,患者在六个时间点(术前、2 周、3 个月、6 个月、12 个月术后)完成了该仪器。患者还完成了前颅底(ASB)问卷和鼻鼻窦结局测试(SNOT-22),以便与 SBI 进行比较。
五个中心共纳入 187 例患者,其中 121 例采用内镜手术。内部一致性(Cronbach's alpha=0.95)和 12 个月和 12 个月加 2 周的重测(组内相关系数>0.90)非常好。总 SBI 评分与 ASB 评分之间存在很强的相关性(r=0.810 至 0.869,p<0.001),鼻域 SBI 评分与 SNOT-22 评分之间存在中度相关性(r=-0.616 至-0.738,p<0.001),表明了同时效度。SBI 评分的变化与总体 QOL 变化之间的中度相关性(r=0.4942,p<0.001)表明了收敛效度。最小的临床重要差异(总体 HR-QOL 变化为“好一点”或“差一点”)为 6.0。
SBI 问卷对接受内镜和开放方法治疗的患者可靠且有效,可用于评估这些情况下的 HR-QOL。